These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12078125)

  • 21. Efficacy of oral vaccination in the final stage of fox rabies elimination in Switzerland.
    Bugnon P; Breitenmoser U; Peterhans E; Zanoni R
    J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):433-7. PubMed ID: 15606866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report of the Fifth AREB Meeting Ho Chi Minh City, Vietnam, 17-20 November 2008.
    Dodet B;
    Vaccine; 2009 Apr; 27(18):2403-7. PubMed ID: 19368779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization.
    Root JJ; McLean RG; Slate D; MacCarthy KA; Osorio JE
    BMC Immunol; 2008 Oct; 9():57. PubMed ID: 18834520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli.
    Motoi Y; Sato K; Hatta H; Morimoto K; Inoue S; Yamada A
    Vaccine; 2005 Apr; 23(23):3026-32. PubMed ID: 15811649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
    Rupprecht CE; Hanlon CA; Slate D
    Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postexposure treatment of rabies infection: can it be done without immunoglobulin?
    Wilde H; Khawplod P; Hemachudha T; Sitprija V
    Clin Infect Dis; 2002 Feb; 34(4):477-80. PubMed ID: 11797174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the antibody response to vaccination against rabies.
    Jakel V; König M; Cussler K; Hanschmann K; Thiel HJ
    Dev Biol (Basel); 2008; 131():431-7. PubMed ID: 18634505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis against rabies.
    Wilde H; Hemachudha T
    N Engl J Med; 2005 Apr; 352(15):1608-10; author reply 1608-10. PubMed ID: 15832456
    [No Abstract]   [Full Text] [Related]  

  • 30. Appropriate rabies postexposure prophylaxis.
    McCauley T; Jones TF; Swinger G
    Tenn Med; 2003 Mar; 96(3):135-7. PubMed ID: 12666375
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 65 years of experience and innovation in protection against rabies: antirabies station (former Pasteur Institute) in Zagreb 1981-1983.
    Vodopija I; Smerdel S; Ljubicic M; Baklaic Z; Svjetlicic M; Lujkic M
    Behring Inst Mitt; 1984 Nov; (76):165-73. PubMed ID: 6395851
    [No Abstract]   [Full Text] [Related]  

  • 34. Equine rabies immunoglobulin: a study on its clinical safety.
    Satpathy DM; Sahu T; Behera TR
    J Indian Med Assoc; 2005 Apr; 103(4):238, 241-2. PubMed ID: 16173435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y; Zhang S; Ma G; Zhang F; Hu R
    Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunity in the prevention of rabies.
    Both L; Banyard AC; van Dolleweerd C; Horton DL; Ma JK; Fooks AR
    Lancet Infect Dis; 2012 May; 12(5):397-407. PubMed ID: 22541629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis against rabies.
    Van den Enden E
    N Engl J Med; 2005 Apr; 352(15):1608-10; author reply 1608-10. PubMed ID: 15832455
    [No Abstract]   [Full Text] [Related]  

  • 39. Case 21-1998: rabies.
    Wilde H
    N Engl J Med; 1999 Jan; 340(1):64-5; author reply 65. PubMed ID: 9882221
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rabies in Chile: 1989-2005].
    Favi C M; Rodríguez A L; Espinosa M C; Yung P V
    Rev Chilena Infectol; 2008 Apr; 25(2):S8-13. PubMed ID: 18425219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.